Drug
Pegfilgrastim-bmez
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Brain Oedema | 27 | 75.1 | 78.6 | signal |
| 2 | Metastases To Central Nervous System | 23 | 63.1 | 65.6 | signal |
| 3 | Candida Infection | 29 | 61.0 | 64.1 | signal |
| 4 | Skin Fissures | 25 | 46.5 | 48.5 | signal |
| 5 | C-reactive Protein Increased | 30 | 28.9 | 30.4 | signal |
| 6 | Restlessness | 29 | 27.8 | 29.1 | signal |
| 7 | Breast Cancer Metastatic | 7 | 22.9 | 23.2 | signal |
| 8 | Eczema | 25 | 17.4 | 18.2 | signal |
| 9 | Hyperthyroidism | 6 | 14.5 | 14.7 | signal |
| 10 | Cytokine Release Syndrome | 7 | 12.9 | 13.0 | signal |
| 11 | Neutropenia | 48 | 12.4 | 13.4 | signal |
| 12 | Drug Reaction With Eosinophilia And Systemic Symptoms | 9 | 12.4 | 12.5 | signal |
| 13 | Skin Haemorrhage | 5 | 12.2 | 12.2 | signal |
| 14 | Toxic Skin Eruption | 3 | 10.4 | 10.5 | signal |
| 15 | Neoplasm Malignant | 18 | 9.5 | 9.7 | signal |
| 16 | Needle Issue | 7 | 8.6 | 8.7 | signal |